On May 19, 2021, Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Jeff Merkley (D-OR) introduced The Hemp Access and Consumer Safety Act of 2021 (the “Act”), which generally provides a legal pathway for certain hemp-derived cannabidiol (“CBD”) products.
Currently, all CBD and CBD products are regulated by the Food and Drug Administration (the “FDA”) pursuant to the Federal Food, Drug, and Cosmetic Act (the “FDCA”). As a CBD derivative has been approved by the FDA in a currently-marketed drug, CBD cannot, as a matter of law under the FDCA, be lawfully placed into commerce as a food or dietary supplement at this time.
As provided within the Act, CBD and CBD products could be placed into commerce as a food or dietary supplement under the FDCA. Please note that all CBD and CBD products would remain subject to the specific food and/or dietary supplement compliance obligations as provided within the FDCA.